CORRECTION

Transpl. Int., 09 October 2023

Volume 36 - 2023 | https://doi.org/10.3389/ti.2023.12088

Corrigendum: Five-Year Outcome After Continuous Flow LVAD With Full-Magnetic (HeartMate 3) Versus Hybrid Levitation System (HeartWare): A Propensity-Score Matched Study From an All-Comers Multicentre Registry

  • 1. Division of Cardiac Surgery, University Hospital of Verona, Verona, Italy

  • 2. Division of Cardiac Surgery, S. Orsola University Hospital, IRCCS Bologna, Bologna, Italy

  • 3. City of Health and Science Hospital, Cardiac Surgery University Unit, University of Turin, Turin, Italy

  • 4. Division of Cardiac Surgery, Ospedale S. Maria della Misericordia, Udine, Italy

  • 5. Division of Cardiac Surgery, Papa Giovanni XXII Hospital of Bergamo, Bergamo, Italy

  • 6. Division of Cardiac Surgery, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy

  • 7. Division of Cardiac Surgery, San Camillo Forlanini Hospital, Rome, Italy

Article metrics

586

Views

311

Downloads

In the original article, there was a mistake in the Graphical Abstract as published. The propensity-score matching survival was incorrectly given as “64.1% vs. 81.3% (p .02)”. The correct values are “64.1% for HM3 vs. 41.7% in HVAD (p 0.02)”. The Kaplan-Meier curve is correct, it was just a transcription error.

GRAPHICAL ABSTRACT

GRAPHICAL ABSTRACT

The corrected Graphical Abstract appears below.

The same mistake was present in the text body. A correction has been made to the Abstract and to the Results section:

Abstract: “The propensity-score matching analysis (130 pairs of HVAD vs. HM3) confirmed a significantly lower 5 years survival (41.7% vs. 64.1%; p 0.02)…”

Results, Propensity Matched Population: “HVAD patients confirmed a significantly lower 5 years survival (64.1% vs. 41.7%; p 0.02) (Figure 2B)…”

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Summary

Keywords

continuous-flow LVAD, HeartMate3, HeartWare, full-magnetic levitation pump, hybrid levitation system pump

Citation

Francica A, Loforte A, Attisani M, Maiani M, Iacovoni A, Nisi T, Comisso M, Terzi A, De Bonis M, Vendramin I, Boffini M, Musumeci F, Luciani GB, Rinaldi M, Pacini D and Onorati F (2023) Corrigendum: Five-Year Outcome After Continuous Flow LVAD With Full-Magnetic (HeartMate 3) Versus Hybrid Levitation System (HeartWare): A Propensity-Score Matched Study From an All-Comers Multicentre Registry. Transpl Int 36:12088. doi: 10.3389/ti.2023.12088

Received

21 September 2023

Accepted

25 September 2023

Published

09 October 2023

Volume

36 - 2023

Updates

Copyright

© 2023 Francica, Loforte, Attisani, Maiani, Iacovoni, Nisi, Comisso, Terzi, De Bonis, Vendramin, Boffini, Musumeci, Luciani, Rinaldi, Pacini and Onorati.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Alessandra Francica,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Figures

Cite article

Copy to clipboard


Export citation file


Share article